Hello, welcome to Tosun!
会员中心

Product introduction:

Fluvastatin sodium is a kind of commonly used antilipidemic drug, which has a very good antilipidemic effect. It is also a fully synthetic cholesterol lowering drug, belonging to the methylglutaryl CoA reductase inhibitor, which mainly plays a role in the liver. It can convert HMG CoA into 3-methyl-3,5-dihydroxyvaleric acid, which can inhibit endogenous cholesterol synthesis, reduce the cholesterol content in liver cells, stimulate the synthesis of low-density lipoprotein (LDL) receptor, and improve the intake of LDL particles

市场价:

  • Product information
  • 产品描述
  • 参数配置


1、 Product introduction

Chinese Name

English Name

Declaration Type

Department

Reportable Dosage Form

Declaration Progress 

Patent Term

DMF
氟伐他汀钠Fluvastatin5+4Endocrine Departmentcapsule

Already accepted

No core patentCEP,USDMF

[Indications]


Hypercholesterolemia and hyperlipidemia; primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Ⅱ A and Ⅱ b) that are not completely controlled by diet


[Advantages]


1. The inhibition of HMG CoA reductase and cholesterol biosynthesis in vivo is stronger than lovastatin

2. The absorption was rapid and complete after oral administration. Before entering the systemic circulation, it is absorbed by the liver and excreted directly with bile. Before excretion, part of it is metabolized


[loading capacity]

20mg/40mg/80mg


[target / Mechanism]

HMG CoA reductase inhibitor


[time to market + EU / US]

Approved by FDA in December 1993


[medical insurance]

In 2009, the national western medicine class B, limited to second-line drugs


2、 Original research enterprise

Fluvastatin 氟伐他汀钠                         CAS:93957-55-2

      Novartis AG is a leading multinational company in the global pharmaceutical and consumer health industries. Novartis is committed to research, develop and promote innovative products to help people cure diseases, alleviate pain and improve the quality of life.


 Fluvastatin 氟伐他汀钠                         CAS:93957-55-2

Guangzhou Tosun Pharmaceutical Ltd

FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663

Tel: +86-20-66392521; Fax: +86-20-66392525

Fluvastatin sodium is a kind of commonly used antilipidemic drug, which has a very good antilipidemic effect. It is also a fully synthetic cholesterol lowering drug, belonging to the methylglutaryl CoA reductase inhibitor, which mainly plays a role in the liver. It can convert HMG CoA into 3-methyl-3,5-dihydroxyvaleric acid, which can inhibit endogenous cholesterol synthesis, reduce the cholesterol content in liver cells, stimulate the synthesis of low-density lipoprotein (LDL) receptor, and improve the intake of LDL particles

安全性高、国内申报企业少

热门关键词: 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
MapsXML Maps  Maps
Phone

(86)18922121079

(86)18026299762

TOP